National Institute for Innovation in Manufacturing Biopharmaceuticals Issues Public Comment on FDA Notice
2021-12-14
zz-Public Comments2021-12-14
Targeted News Service
WASHINGTON, Dec. 14 -- Gene Schaefer, senior fellow and chair of the Regulatory Considerations Committee at the National Institute for Innovation in Manufacturing Biopharmaceuticals, Newark, Delaware, . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, Dec. 14 -- Gene Schaefer, senior fellow and chair of the Regulatory Considerations Committee at the National Institute for Innovation in Manufacturing Biopharmaceuticals, Newark, Delaware, . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
Copyright © Targeted News Service, 2021